Application and progress of new technologies and new materials in the treatment of pathological scar

Front Chem. 2024 May 1:12:1389399. doi: 10.3389/fchem.2024.1389399. eCollection 2024.

Abstract

Pathological scars (PS), including hypertrophic scars (HTS) and keloids, are a common complication of poor wound healing that significantly affects patients' quality of life. Currently, there are several treatment options for PS, including surgery, drug therapy, radiation therapy, and biological therapy. However, these treatments still face major challenges such as low efficacy, high side effects, and a high risk of recurrence. Therefore, the search for safer and more effective treatments is particularly urgent. New materials often have less immune rejection, good histocompatibility, and can reduce secondary damage during treatment. New technology can also reduce the side effects of traditional treatments and the recurrence rate after treatment. Furthermore, derivative products of new materials and biomaterials can improve the therapeutic effect of new technologies on PS. Therefore, new technologies and innovative materials are considered better options for enhancing PS. This review concentrates on the use of two emerging technologies, microneedle (MN) and photodynamic therapy (PDT), and two novel materials, photosensitizers and exosomes (Exos), in the treatment of PS.

Keywords: exosome (EXO); microneedle (MN); new biological materials; new technologies; pathological scar; photodynamic therapy (PDT); photosensitizer.

Publication types

  • Review

Grants and funding

The author(s) declare that financial support was received for the research, authorship, and/or publication of this article. This paper was supported by the Shandong Provincial Natural Science Foundation (ZR2022MH191) to ZW and the Qingdao Science and Technology Benefit People Plan Demonstration Project (24-1-8-smjk-11-nsh) to ZW. All authors state that the financial support did not affect the opinion of the article or the statistical analysis of the objective results of the study data or its reporting.